Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Addressing certain behaviors in telogen effluvium patients can improve management and reduce costs.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Type 3 acromegaly patients have more health issues and higher death risk.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Severe hair loss links to metabolic issues in older men with psoriasis.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

A quick and simple method was created to identify minoxidil in hair-growth products using micellar electrokinetic capillary chromatography.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Mitochondrial genes help predict breast cancer outcomes and spread.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Dermatological diseases affect women's work performance more than men's.